Gerald E Quirk Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

Gerald E Quirk is Chief Legal & Compliance Offic of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of SYRS, which is worth approximately $0. The most recent transaction as insider was on Nov 19, 2024, when has been sold 46,657 shares (Common Stock) at a price of $0.22 per share, resulting in proceeds of $10,264. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Gerald E Quirk Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 19 2024	SELL Open market or private sale	$10,264 $0.22 p/Share	46,657 Reduced 100.0%	0 Common Stock
Sep 30 2024	SELL Payment of exercise price or tax liability	$6,510 $2.1 p/Share	3,100 Reduced 6.23%	46,657 Common Stock
Sep 30 2024	BUY Exercise of conversion of derivative security	-	10,000 Added 16.73%	49,757 Common Stock
Mar 28 2024	SELL Payment of exercise price or tax liability	$39,387 $5.59 p/Share	7,046 Reduced 15.05%	39,757 Common Stock
Mar 27 2024	BUY Exercise of conversion of derivative security	-	22,500 Added 32.47%	46,803 Common Stock
Oct 19 2023	SELL Payment of exercise price or tax liability	$14,483 $2.1 p/Share	6,897 Reduced 22.11%	24,303 Common Stock
Oct 11 2023	BUY Exercise of conversion of derivative security	-	22,500 Added 41.9%	31,200 Common Stock

GEQ

Gerald E Quirk

Chief Legal & Compliance Offic

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Value

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Syros Pharmaceuticals, Inc.

Track Activities on SYRS

Account